Cellular expression pattern of the protease-activated receptor 4 in the hippocampus in naïve rats and after global ischaemia.
A pronounced hippocampal expression of the Protease-activated Receptor 4 (PAR4) has recently been shown. In the current study the authors define the PAR4-associated sub-cellular structures and the influence of global ischaemia on the expression of PAR4. For that purpose the authors performed double labelling with fluorescence immunohistochemistry on tissue from naïve and post-ischaemic rats. In naïve animals - apart from the expression in granular and pyramidal neurons - there was an intensive lamellar expression of PAR4 in the CA4 region. Further analysis revealed that PAR4 was localised exclusively on mossy fibre axons in CA4 as detected by double-labelling with calbindin D-28k, but there was no overlap with markers of the neuronal cell body, interneurons, and post-synaptic, pre-synaptic and dendritic structures. Three and 14 days post ischaemia, CA1 neurons were degenerated and, consequently, there was no PAR4 signal in the CA1 band. In most other hippocampal structures no change in the PAR4 expression was detectable, with the exception of the CA3 region. Here, the fibre-associated PAR4 signal was diminished and disintegrated post ischaemia. Additionally, a redistribution from the membrane-bound neuronal localisation of PAR4 in control animals to a diffuse localisation all over the cell soma was revealed in the CA3 area 14 days post ischaemia. In conclusion, the current study proves for the first time that PAR4 is localised in mossy fibre axons. The altered expression in CA3 neurons after ischaemia indicates that PAR4 may be involved in post-ischaemic adaptive mechanisms.
Leibniz Institute for Neurobiology, Magdeburg, Germany.
P
P
Henrich-Noack
M
M
Riek-Burchardt
K G
KG
Reymann
G
G
Reiser
D048868:Adaptor Proteins, Signal Transducing / Q000378:metabolism; D000818:Animals; D064026:Calbindins; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000502:physiology*; D006624:Hippocampus / Q000166:cytology* / Q000378:metabolism*; D007511:Ischemia / Q000473:pathology*; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D004676:Myelin Basic Protein / Q000378:metabolism; D009419:Nerve Tissue Proteins; D010751:Phosphopyruvate Hydratase / Q000378:metabolism; D051381:Rats; D018179:Receptors, Thrombin / Q000235:genetics / Q000378:metabolism*; D064030:S100 Calcium Binding Protein G / Q000378:metabolism; D013347:Subcellular Fractions / Q000378:metabolism; D016708:Synaptophysin / Q000378:metabolism; D013997:Time Factors
D048868:Adaptor Proteins, Signal Transducing; D064026:Calbindins; C489787:MAP2 protein, rat; D008869:Microtubule-Associated Proteins; D004676:Myelin Basic Protein; D009419:Nerve Tissue Proteins; D018179:Receptors, Thrombin; D064030:S100 Calcium Binding Protein G; C120532:Shank3 protein, rat; D016708:Synaptophysin; D010751:Phosphopyruvate Hydratase; C112908:protease-activated receptor 4